Seroprevalence and indexes of IgG antibodies for SARS-CoV-2 infection among People Living With HIV, tuberculosis patients and healthcare workers, in Salvador, Brazil

Introduction: COVID-19 can trigger different clinical presentations in distinct population groups, some of which are considered at higher risk of SARS-CoV-2 infection. Little is known about the susceptibility of certain populations to the infection. Objectives: We aimed to determine the prevalence o...

Full description

Bibliographic Details
Main Authors: Daniele Souza de Santana, Eduardo Martins Netto, Sara Nunes Vaz, Paulo Henrique Dantas, Carlos Brites
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Brazilian Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1413867023000715
_version_ 1797660549725552640
author Daniele Souza de Santana
Eduardo Martins Netto
Sara Nunes Vaz
Paulo Henrique Dantas
Carlos Brites
author_facet Daniele Souza de Santana
Eduardo Martins Netto
Sara Nunes Vaz
Paulo Henrique Dantas
Carlos Brites
author_sort Daniele Souza de Santana
collection DOAJ
description Introduction: COVID-19 can trigger different clinical presentations in distinct population groups, some of which are considered at higher risk of SARS-CoV-2 infection. Little is known about the susceptibility of certain populations to the infection. Objectives: We aimed to determine the prevalence of COVID-19 among People Living With HIV/AIDS (PLWH) attending a tertiary public hospital in Salvador, Brazil, patients with active pulmonary tuberculosis and Hospital's Healthcare Workers (HCW), and to compare their SARS-CoV-2 antibody levels. Methods: In this observational study we included 2294 participants from June 9, 2020 to August 10, 2021. IgG SARS-CoV-2 antibodies from all participants (275 PLWH, 42 with active tuberculosis and 1977 healthcare workers) were measured. Prevalence of COVID-19 and antibodies indexes were compared across groups. Results: We detected a higher prevalence of COVID-19 in patients with active tuberculosis (42.9%) than in PLWH (22.5%) or HCW (11.7%). Previously vaccinated participants with a COVID-19 history had median higher IgG antibody indexes (8.2; IQR: 5.5‒10) than those vaccinated who did not have COVID-19 until the time of this study (4.1; IQR: 1.6‒6.2, p < 0.001). Conclusion: Prevalence of previous SARS-CoV-2 infection was higher among tuberculosis patients than that found in HCW and PLWH, but antibodies levels were similar across groups.
first_indexed 2024-03-11T18:31:31Z
format Article
id doaj.art-fe877e2ec3c3435191b07caa980d5a03
institution Directory Open Access Journal
issn 1413-8670
language English
last_indexed 2024-03-11T18:31:31Z
publishDate 2023-09-01
publisher Elsevier
record_format Article
series Brazilian Journal of Infectious Diseases
spelling doaj.art-fe877e2ec3c3435191b07caa980d5a032023-10-13T11:03:51ZengElsevierBrazilian Journal of Infectious Diseases1413-86702023-09-01275102811Seroprevalence and indexes of IgG antibodies for SARS-CoV-2 infection among People Living With HIV, tuberculosis patients and healthcare workers, in Salvador, BrazilDaniele Souza de Santana0Eduardo Martins Netto1Sara Nunes Vaz2Paulo Henrique Dantas3Carlos Brites4Universidade Federal da Bahia (UFBA/EBSERH), Hospital Universitário Professor Edgard Santos, Laboratório de Pesquisa em Infectologia, Salvador, BA, BrazilUniversidade Federal da Bahia (UFBA/EBSERH), Hospital Universitário Professor Edgard Santos, Laboratório de Pesquisa em Infectologia, Salvador, BA, Brazil; Fundação Bahiana de Infectologia, Salvador, BA, BrazilUniversidade Federal da Bahia (UFBA/EBSERH), Hospital Universitário Professor Edgard Santos, Laboratório de Pesquisa em Infectologia, Salvador, BA, Brazil; Fundação Bahiana de Infectologia, Salvador, BA, BrazilUniversidade Federal da Bahia (UFBA/EBSERH), Hospital Universitário Professor Edgard Santos, Laboratório de Pesquisa em Infectologia, Salvador, BA, BrazilUniversidade Federal da Bahia (UFBA/EBSERH), Hospital Universitário Professor Edgard Santos, Laboratório de Pesquisa em Infectologia, Salvador, BA, Brazil; Fundação Bahiana de Infectologia, Salvador, BA, Brazil; Corresponding author.Introduction: COVID-19 can trigger different clinical presentations in distinct population groups, some of which are considered at higher risk of SARS-CoV-2 infection. Little is known about the susceptibility of certain populations to the infection. Objectives: We aimed to determine the prevalence of COVID-19 among People Living With HIV/AIDS (PLWH) attending a tertiary public hospital in Salvador, Brazil, patients with active pulmonary tuberculosis and Hospital's Healthcare Workers (HCW), and to compare their SARS-CoV-2 antibody levels. Methods: In this observational study we included 2294 participants from June 9, 2020 to August 10, 2021. IgG SARS-CoV-2 antibodies from all participants (275 PLWH, 42 with active tuberculosis and 1977 healthcare workers) were measured. Prevalence of COVID-19 and antibodies indexes were compared across groups. Results: We detected a higher prevalence of COVID-19 in patients with active tuberculosis (42.9%) than in PLWH (22.5%) or HCW (11.7%). Previously vaccinated participants with a COVID-19 history had median higher IgG antibody indexes (8.2; IQR: 5.5‒10) than those vaccinated who did not have COVID-19 until the time of this study (4.1; IQR: 1.6‒6.2, p < 0.001). Conclusion: Prevalence of previous SARS-CoV-2 infection was higher among tuberculosis patients than that found in HCW and PLWH, but antibodies levels were similar across groups.http://www.sciencedirect.com/science/article/pii/S1413867023000715SARS-CoV-2SerologyHIVTuberculosis
spellingShingle Daniele Souza de Santana
Eduardo Martins Netto
Sara Nunes Vaz
Paulo Henrique Dantas
Carlos Brites
Seroprevalence and indexes of IgG antibodies for SARS-CoV-2 infection among People Living With HIV, tuberculosis patients and healthcare workers, in Salvador, Brazil
Brazilian Journal of Infectious Diseases
SARS-CoV-2
Serology
HIV
Tuberculosis
title Seroprevalence and indexes of IgG antibodies for SARS-CoV-2 infection among People Living With HIV, tuberculosis patients and healthcare workers, in Salvador, Brazil
title_full Seroprevalence and indexes of IgG antibodies for SARS-CoV-2 infection among People Living With HIV, tuberculosis patients and healthcare workers, in Salvador, Brazil
title_fullStr Seroprevalence and indexes of IgG antibodies for SARS-CoV-2 infection among People Living With HIV, tuberculosis patients and healthcare workers, in Salvador, Brazil
title_full_unstemmed Seroprevalence and indexes of IgG antibodies for SARS-CoV-2 infection among People Living With HIV, tuberculosis patients and healthcare workers, in Salvador, Brazil
title_short Seroprevalence and indexes of IgG antibodies for SARS-CoV-2 infection among People Living With HIV, tuberculosis patients and healthcare workers, in Salvador, Brazil
title_sort seroprevalence and indexes of igg antibodies for sars cov 2 infection among people living with hiv tuberculosis patients and healthcare workers in salvador brazil
topic SARS-CoV-2
Serology
HIV
Tuberculosis
url http://www.sciencedirect.com/science/article/pii/S1413867023000715
work_keys_str_mv AT danielesouzadesantana seroprevalenceandindexesofiggantibodiesforsarscov2infectionamongpeoplelivingwithhivtuberculosispatientsandhealthcareworkersinsalvadorbrazil
AT eduardomartinsnetto seroprevalenceandindexesofiggantibodiesforsarscov2infectionamongpeoplelivingwithhivtuberculosispatientsandhealthcareworkersinsalvadorbrazil
AT saranunesvaz seroprevalenceandindexesofiggantibodiesforsarscov2infectionamongpeoplelivingwithhivtuberculosispatientsandhealthcareworkersinsalvadorbrazil
AT paulohenriquedantas seroprevalenceandindexesofiggantibodiesforsarscov2infectionamongpeoplelivingwithhivtuberculosispatientsandhealthcareworkersinsalvadorbrazil
AT carlosbrites seroprevalenceandindexesofiggantibodiesforsarscov2infectionamongpeoplelivingwithhivtuberculosispatientsandhealthcareworkersinsalvadorbrazil